1. Home
  2. CADL vs CRESY Comparison

CADL vs CRESY Comparison

Compare CADL & CRESY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

N/A

Current Price

$9.92

Market Cap

739.2M

Sector

Health Care

ML Signal

N/A

Logo Cresud S.A.C.I.F. y A.

CRESY

Cresud S.A.C.I.F. y A.

N/A

Current Price

$11.44

Market Cap

804.3M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
CADL
CRESY
Founded
1999
1936
Country
United States
Argentina
Employees
55
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Real Estate
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
739.2M
804.3M
IPO Year
2021
1997

Fundamental Metrics

Financial Performance
Metric
CADL
CRESY
Price
$9.92
$11.44
Analyst Decision
Strong Buy
Buy
Analyst Count
9
2
Target Price
★ $21.75
$15.86
AVG Volume (30 Days)
★ 1.1M
288.8K
Earning Date
11-12-2026
11-09-2026
Dividend Yield
N/A
★ 5.26%
EPS Growth
★ 58.62
N/A
EPS
N/A
★ N/A
Revenue
★ $125,000.00
N/A
Revenue This Year
N/A
$14.96
Revenue Next Year
N/A
$19.02
P/E Ratio
★ N/A
$6.92
Revenue Growth
N/A
N/A
52 Week Low
$4.35
$8.91
52 Week High
$14.00
$14.21

Technical Indicators

Market Signals
Indicator
CADL
CRESY
Relative Strength Index (RSI) 36.74 43.38
Support Level $9.18 $11.18
Resistance Level $10.59 $11.74
Average True Range (ATR) 0.56 0.44
MACD -0.12 -0.11
Stochastic Oscillator 15.26 15.91

Price Performance

Historical Comparison
CADL
CRESY

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

About CRESY Cresud S.A.C.I.F. y A.

Cresud SACIF y A is a Latin American agricultural firm producing basic commodities with a growing presence in Argentina, Brazil, and other countries through its investment in Brasilagro. It focuses on grains, sugarcane, and cattle farming, acquiring and developing agricultural properties for production or value appreciation, and occasionally selling appreciated land. It also leases land and offers agency and agro-industrial services. Operations are divided into two segments: agricultural business (production, land transformation and sales, corporate services) and urban properties and investments (shopping malls, offices, sales, developments, hotels, and related activities).

Share on Social Networks: